Pharmacom Store


Coughing after testosterone injection.

Results 1 to 15 of 15
  1. #1
    Member

    GottaGetGains's Avatar


    Join Date
    Sep 2019
    Posts
    81

    Thanks Thanks Given 
    32
    Thanks Thanks Received 
    21
    Thanked in
    12 Posts
    Rep Points
    4495299

    Coughing after testosterone injection.

    Maybe a mere coincidence, but I suddenly am coughing a lot. There was blood after I pulled the needle out of my left glute. It's been 24 hours now. Thoughts on this?
    What would happen if I injected the oil into a vein?

  2. #2
    Senior Member


    Join Date
    Aug 2013
    Posts
    859

    Thanks Thanks Given 
    83
    Thanks Thanks Received 
    123
    Thanked in
    91 Posts
    Rep Points
    2147483647

    Quote Originally Posted by GottaGetGains View Post
    Maybe a mere coincidence, but I suddenly am coughing a lot. There was blood after I pulled the needle out of my left glute. It's been 24 hours now. Thoughts on this?
    What would happen if I injected the oil into a vein?
    Happens more often with Tren. After it enters your bloodstream then it exits out of your lungs. Only had it happen a few times with test.

    Sent from my LM-X410(FG) using Tapatalk

  3. #3
    Super Moderator
    SUPER MOD

    WesleyInman's Avatar


    Join Date
    Jul 2014
    Posts
    2,854

    Thanks Thanks Given 
    1,354
    Thanks Thanks Received 
    819
    Thanked in
    510 Posts
    Rep Points
    2147483647

    It's called Prostaglandins.

    It is more common in Tren or Progesterone compounds but it can and does happen in testosterone injections.

    You want to research the process of prostaglandins in the lungs, upon injection. I actually am very well versed in it, but do not have the time to explain. It's complicated, but this is the reason.

  4. #4
    Member

    GottaGetGains's Avatar


    Join Date
    Sep 2019
    Posts
    81

    Thanks Thanks Given 
    32
    Thanks Thanks Received 
    21
    Thanked in
    12 Posts
    Rep Points
    4495299

    Quote Originally Posted by WesleyInman View Post
    It's called Prostaglandins.

    It is more common in Tren or Progesterone compounds but it can and does happen in testosterone injections.

    You want to research the process of prostaglandins in the lungs, upon injection. I actually am very well versed in it, but do not have the time to explain. It's complicated, but this is the reason.
    I will definitely do some research on this tonight. thank you for the insight.

    In other words... is the bad? How long does it last?

  5. #5
    Senior Member


    Join Date
    Aug 2013
    Posts
    859

    Thanks Thanks Given 
    83
    Thanks Thanks Received 
    123
    Thanked in
    91 Posts
    Rep Points
    2147483647

    Quote Originally Posted by GottaGetGains View Post
    I will definitely do some research on this tonight. thank you for the insight.

    In other words... is the bad? How long does it last?
    It only lasts a minute or 2. Try not to nick a vein and you should be good.

    Sent from my LM-X410(FG) using Tapatalk

  6. #6
    Senior Member

    Wiseguy's Avatar


    Join Date
    Nov 2013
    Posts
    804

    Thanks Thanks Given 
    11
    Thanks Thanks Received 
    182
    Thanked in
    128 Posts
    Rep Points
    2147483647

    Its happened to me many times. I cough couple of times and take deep breaths and usually is gone in 30 seconds.

  7. #7
    Member

    GottaGetGains's Avatar


    Join Date
    Sep 2019
    Posts
    81

    Thanks Thanks Given 
    32
    Thanks Thanks Received 
    21
    Thanked in
    12 Posts
    Rep Points
    4495299

    Well maybe i have a legit cough coming on from the weather change because its been over 24 hours now.
    Guess I just panicked.
    Thanks everyone for the input

  8. #8
    Senior Member

    Milford King's Avatar


    Join Date
    Jan 2018
    Location
    Milky Way
    Posts
    5,925

    Thanks Thanks Given 
    2,447
    Thanks Thanks Received 
    2,756
    Thanked in
    1,777 Posts
    Rep Points
    2147483647

    I have learned from personal experience that the more scar tissue you have the easier it is to get the dreaded cough (feels like congestive heart failure).

    Dont worry. You shouldn’t die..... lol

    dude..... find your VG and the other one that’s next to the VG (forgot what iceman told me it was) ... less veins.... start rotating injection sites to avoid build up of scar tissue. Less likely to get cough.

  9. #9
    Member

    GottaGetGains's Avatar


    Join Date
    Sep 2019
    Posts
    81

    Thanks Thanks Given 
    32
    Thanks Thanks Received 
    21
    Thanked in
    12 Posts
    Rep Points
    4495299

    Quote Originally Posted by Milford King View Post
    I have learned from personal experience that the more scar tissue you have the easier it is to get the dreaded cough (feels like congestive heart failure).

    Dont worry. You shouldn’t die..... lol

    dude..... find your VG and the other one that’s next to the VG (forgot what iceman told me it was) ... less veins.... start rotating injection sites to avoid build up of scar tissue. Less likely to get cough.
    Thanks man, this is my first cycle so any thing that goes wrong I am nervous nancy. super panic lol.

  10. #10
    Senior Member

    Milford King's Avatar


    Join Date
    Jan 2018
    Location
    Milky Way
    Posts
    5,925

    Thanks Thanks Given 
    2,447
    Thanks Thanks Received 
    2,756
    Thanked in
    1,777 Posts
    Rep Points
    2147483647

    Oh I get it bud. This is my 750th cycle and I’m sketched out every single time ... scary shit dude. I got tattoos and inject myself and still hate needles.

    First time the cough hit me, started packing all my gear up and writing a note to my wife.... thought I was done son

  11. #11
    Member

    GottaGetGains's Avatar


    Join Date
    Sep 2019
    Posts
    81

    Thanks Thanks Given 
    32
    Thanks Thanks Received 
    21
    Thanked in
    12 Posts
    Rep Points
    4495299

    Quote Originally Posted by Milford King View Post
    Oh I get it bud. This is my 750th cycle and I’m sketched out every single time ... scary shit dude. I got tattoos and inject myself and still hate needles.

    First time the cough hit me, started packing all my gear up and writing a note to my wife.... thought I was done son
    Lmfao. Makes me feel better to hear that anyway...
    I just want this first cycle to go smoothly. Taking all precautions and advice that I can get. So thank you!

  12. #12
    Senior Member

    Dukey's Avatar


    Join Date
    Sep 2017
    Location
    Planet Earth
    Posts
    756

    Thanks Thanks Given 
    1,609
    Thanks Thanks Received 
    339
    Thanked in
    249 Posts
    Rep Points
    330005874

    Quote Originally Posted by Milford King View Post
    Oh I get it bud. This is my 750th cycle and I’m sketched out every single time ... scary shit dude. I got tattoos and inject myself and still hate needles.

    First time the cough hit me, started packing all my gear up and writing a note to my wife.... thought I was done son
    . Me too. I hit some tren/eq base. My ears started ringing and my chest instantly got tight and started hurting. I was home alone in my bathroom, I thought to myself "WTF this is how it's going to end? They'll find me dead in the bathroom with my sweats around my ankles, syringe next to me? ". I took a few deep breaths, it went away, I went to the gym and had phenomenal workout. I just pinned 1/2ml after that. Wasn't as bad. I also noticed that feeling of death coming was not every time. So I'm assuming now it's because of the scar tissue/injection sight discussed above. You just hit things just right sometimes and injections can do that shit to you.

    Sent from my Z839 using Tapatalk

  13. #13
    EuroPharmacies Ambassador
    SUPER MOD

    Vision's Avatar


    Join Date
    Aug 2013
    Location
    Anabolic Erudite
    Posts
    15,158

    Thanks Thanks Given 
    2,281
    Thanks Thanks Received 
    3,735
    Thanked in
    2,441 Posts
    Rep Points
    2147483647

    Quote Originally Posted by WesleyInman View Post
    It's called Prostaglandins.
    Quote Originally Posted by WesleyInman View Post

    It is more common in Tren or Progesterone compounds but it can and does happen in testosterone injections.

    You want to research the process of prostaglandins in the lungs, upon injection. I actually am very well versed in it, but do not have the time to explain. It's complicated, but this is the reason.
    Wesley my brutha from an other mutha whats good man? Hit me up in PM question for ya....BTW It's actually called POME, "Pulnonary Oil Microbolism"..

    This can happen with testosterone an just about any injection..

    However, with tren this "known tren cough" is induced by way of Trenbolone increasing the rise of "prostaglandin" production which can have great influence over bronchial constriction..This is what you mentioned but this happens by the allergic like response, I'll explain more..

    Tren/Injectioncough explained (Backed by a clinical studies)
    Over the years I have seen numerous threads containing questions and concerns in regards to “Tren cough” or “Post injection cough”..
    As it seems to be a phenomenon in the Body Building community,and people could not come up with a definitive answer/reasonable explanation other than “Some of your compound must have entered the blood stream by means of nicking a vein “, other times I see people posting ideas and theories,failing to provide any conclusive evidence..Well today I’m going to explain exactly what’s taking place inside your body/respiratory system post injection..This may be old news for some,and knew news for others!
    I myself have experienced this “coughing/struggling to breath”on numerous occasions,and not just from Trenbolone,and believe it or not I’ve experienced this with Testosterone in the presence of a deep IM (intramuscular Injections) shot..

    Why does this take place? What is the causes and effects? Can this be avoided?
    There’s a few variables that can be taking place here in regards to the symptoms that one feels almost immediately post IM, ranging from trouble breathing,mild to violent coughing fits,eyes watering,mild to extreme flush feeling,feeling dizzy or faint,pressure in the chest,ext ext. This can last anywhere from 1-3 mins, and at times 5-10 mins (some cases have been reported lasting for days with random coughing fits)..I often hear people advocate that it’s the acetate ester,or most with Tren period..It’s not entire true,but there is some truth behind that,I’ll explain more later..
    However,This can happen with any compound regardless of the ester..


    What is the cause and effects?
    Like I stated prior,there’s a few reasons you could experience this..I’ll start with the leading one!
    It’s known as

    “POME” Pulmonary oil microembolism..What is that?
    It’s simply a case of acute respiratory distress and hypoxemia, following the accidental intravenous injection,nicking a vein with needle or an oil steroid solution or ba/bb and/or oil near capillaries (I’ll enclose a study on this)..The oil solution is carried through the blood stream making is way to the lungs, in which the reaction of coughing is simply your bodies way of clearing it out!
    Speaking of solution, Benzyl Benzoate (BB is found present in MOST UGL products) Is an other agent that’s known for causing respiratory distress, which in this is temporary acute onset of “Anaphylaxis” (I’ll enclose a study on this as well)..


    Can this be avoid?
    Not really because this can happen just about at anytime, but using areas that have less mapping increases less chances of experiencing POME

    Why does this seem to happen most when it pertains to Trenbolone?
    Trenbolone increases the rise of prostaglandin production which can have great influence over bronchial constriction..
    What are prostaglandins? There group of hormone-like lipid compounds/cells that are derived enzymatically from fatty acids that are precursors of Cyclooxygenase & Lipoxygenase..
    Lipoxygenase has some dictation through pathways which is expressed through branches of bronchi, in the entire respiratory system..When the Cox-2 (lipo) levels increase it tends to have restriction or expulsion in the respiratory region..Thus,this is what dicates the “Tren cough”..
    This tends to happen more with the Ace ester as it cause a faster metabolization and a faster rise with the prostaglandin levels!


    Below I have some studies included, I will post them in the post under this reply so reads can choose to look it over or not.. I will leave this post here basic and right to the point..The included studies below may help explain in great detail for those that wish to geek out on this topic!

    Enjoy,
    Vision



  14. #14
    EuroPharmacies Ambassador
    SUPER MOD

    Vision's Avatar


    Join Date
    Aug 2013
    Location
    Anabolic Erudite
    Posts
    15,158

    Thanks Thanks Given 
    2,281
    Thanks Thanks Received 
    3,735
    Thanked in
    2,441 Posts
    Rep Points
    2147483647

    ___________________________________________
    Pulmonary Oil Microembolism (POME) and Anaphylaxis in Controlled Clinical Studies
    Medical Editor: John P. Cunha, DO, FACOEP

    Adverse events attributable to pulmonary oil microembolism and anaphylaxiswere reported in a small number of patients in controlled clinical trials. In the 84-week clinical trial of Aveed, 1 patient experienced a mild coughing fit lasting 10 minutes after his third injection, which was retrospectively attributed to POME. In another clinical trial of intramuscular testosterone undecanoate (1000 mg), a hypogonadal male patient experienced the urge to cough and respiratory distress at 1 minute after his tenth injection, which was also retrospectively attributed to POME.
    During a review that involved adjudication of all cases meeting specific criteria, 9 POME events in 8 patients and 2 events of anaphylaxis among 3,556 patients treated with intramuscular testosterone undecanoate in 18 clinical trials were judged to have occurred.
    Postmarketing Experience
    The following adverse reactions have been identified during post-approval use of Aveed. Because the reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
    Pulmonary Oil Microembolism (POME) and Anaphylaxis
    Serious pulmonary oil microembolism (POME) reactions, involving cough, urge to cough, dyspnea, hyperhidrosis, throat tightening, chest pain, dizziness, andsyncope, have been reported to occur during or immediately after the injection of intramuscular testosterone undecanoate 1000 mg (4 mL) in post-approval use outside the United States. The majority of these events lasted a few minutes and resolved with supportive measures; however, some lasted up to several hours and some required emergency care and/or hospitalization.
    In addition to serious POME reactions, episodes of anaphylaxis, including life-threatening reactions, have also been reported to occur following the injection of intramuscular testosterone undecanoate in post-approval use outside of the United States.
    Both serious POME reactions and anaphylaxis have been reported to occur after any injection of testosterone undecanoate during the course of therapy, including after the first dose.

    __________________________________________________ __

    Anaphylaxis Triggered by Benzyl Benzoate

    Abstract
    We report the first case of an anaphylactic reaction to Reandron 1000 (depot testosterone undecanoate with a castor oil and benzyl benzoate vehicle).
    While considered to have a favourable safety profile, serious complications such as oil embolism and anaphylaxis can occur. In our patient, skin testing identified benzyl benzoate to be the trigger, with no reaction to castor oil or testosterone undecanoate components. As benzyl benzoate exists in multiple ***************, foods, and cosmetics, individual components of *************** should be tested when investigating drug allergies. Doctors should be alert to the potential for serious reactions to any of the components of Reandron 1000.1. Introduction
    In men requiring testosterone therapy, depot testosterone undecanoate (TU) is a useful option. Compared to conventional testosterone esters, depot TU maintains adequate testosterone levels with less frequent injections and has better pharmacokinetics. Specifically, depot TU comparatively achieves higher trough serum testosterone concentrations without the wide variation between peak and trough levels between doses [1]. TU was initially developed in the 1970s as an oral testosterone replacement preparation, with a transdermal patch available in the 1990s [1]. In China, a depot TU preparation with a Chinese teaseed oil vehicle was manufactured for intramuscular use and found to have a long half-life of 21 days, longer than conventionally used testosterone esters [2, 3]. Depot TU is currently marketed with a castor oil and benzyl benzoate vehicle [4], as the castor oil affords an even longer half-life (33.9 days) than the original Chinese depot preparation [2,5].The long-term overall safety profile of depot TU has been generally favourable [6, 7]. Anaphylaxis to depot TU has not been specifically reported although hypersensitivity is listed as an uncommon adverse effect in the manufacturer’s product information [4]. Hypersensitivity reactions have not been described in cohorts who have used this preparation from 4 to 8 years.Here, we report the first documented case of anaphylaxis to Reandron 1000, a depot preparation of TU. This case is notable for the fact that the responsible agent was not the main active ingredient.2. Case Presentation
    A 16-year-old boy with primary hypogonadism due to bilaterally absent testes, but otherwise without remarkable medical history, was converted from monthly intramuscular injections of testosterone esters (Sustanon, Schering-Plough) to depot testosterone undecanoate (Reandron 1000, Bayer) due to debilitating fluctuations in mood and energy levels. There was significant improvement in symptoms on the depot preparation.Within four minutes after his third dose was administered, he developed sweatiness, facial swelling, itching, urticaria, and sensation of throat obstruction with chest tightness. He was normotensive without tachycardia. He was treated with intravenous promethazine and hydrocortisone 250 mg and observed in an emergency department. Adrenaline (epinephrine) was not administered. The differential diagnosis of oil embolism was not pursued in view of the classical clinical features of anaphylaxis.A skin prick test found definite reaction to Reandron 1000 with a 10 × 8 mm wheal, but no reaction to testosterone esters gel or saline solution control. Testing of the components of Reandron 1000 found that non-skin-irritating concentrations of benzyl benzoate resulted in a 10 × 10 mm wheal and smaller peripheral lesions. Neither castor oil nor TU induced a response. His father was tested as a control and did not react to any of the components.Since discontinuation of Reandron 1000, the patient has used topical testosterone ester gel and crystalline testosterone pellets were implanted subcutaneously. There have been no further episodes of anaphylaxis.3. Discussion
    We report a case of anaphylaxis to a depot preparation of TU comprising three components. Testing of each component identified benzyl benzoate as the likely trigger and demonstrates the importance of testing every component when investigating and managing medication-related anaphylaxis. Neither Reandron 1000 nor benzyl benzoate has been previously reported as a trigger for anaphylaxis.Excipients are the components of *************** apart from the active substance. They fulfil a variety of different roles including colouring, flavouring, and alteration of the stability, solubility, durability, or permeability of the active ingredient. These agents are capable of inducing severe adverse drug reactions, particularly in the paediatric population [8]. Immunologically mediated hypersensitivity reactions can manifest as immediate (within 1 hour) onset of urticaria, angioedema, or anaphylaxis. Alternatively, there can be a delayed (>1 hour) onset of mostly cutaneous symptoms which, as in Stevens-Johnson syndrome, can still be severe [9]. In Reandron 1000, the excipient agents are benzyl benzoate and castor oil, while the active ingredient is TU.Benzyl benzoate (chemical formula C14H12O2) is a colourless oily liquid which is rapidly metabolised by the body to benzoic acid and benzyl alcohol [10]. The agent is widely used as an additive in many different ************** and nonpharmaceutical products for human consumption. For instance, it is used as a preservative, a solvent in perfumes, a flavouring agent in foods and medications, and in insecticides and insect repellents [10, 11]. In oil-based vehicles for depot steroids, it lowers viscosity to improve ease of administration [12] and prevents crystallisation of steroids during storage [10, 13]. In testosterone preparations, it is also found in testosterone cypionate (Depo-Testosterone, Pharmacia) but not testosterone esters (Sustanon) or testosterone gel.In its role as a topical insecticide for scabies, benzyl benzoate is applied in a diluted solution with a concentration between 10% and 25%. It is known to cause skin irritation and contact dermatitis in this context, but hypersensitivity reactions have not been recorded in existing studies. No information is available as to whether or not benzyl benzoate possesses the intrinsic ability to induce mast cell degranulation. Databases for adverse reactions have also identified convulsions occurring with ingested benzyl benzoate [10, 14].Although not previously reported, hypersensitivity reactions to benzyl benzoate are unlikely to be isolated to our patient. Its presence in numerous consumer products raises the possibility of underreporting due to lack of awareness and failure to identify it as the trigger. Existing guidelines by the British Society for Allergy and Clinical Immunology [15] recommend skin prick testing if a compatible history of IgE-mediated drug hypersensitivity exists. In our patient, signs and symptoms of anaphylaxis to testosterone therapy and the clinical need for ongoing testosterone therapy warranted such investigation. Although intuitive and in common practice, there are no specific recommendations regarding testing of individual components of ************** preparations in either British or Australian [16] guidelines. In our patient, discovery of a reaction to a single component of the depot vehicle will better guide selection of testosterone replacement therapies. It will also allow him to remain vigilant to benzyl-benzoate-containing products.Castor oil has been used as a vehicle for steroid hormones for decades, prolonging their effect compared to equivalent aqueous suspensions by increasing storage in fatty depots in the body [12]. While there have been no reports of anaphylaxis to castor oil, sudden onset of respiratory symptoms can signify oil-related pulmonary microembolism after entry via the lymphatic or venous system. This complication is rare [17].In this case, our patient received supportive care for anaphylaxis with antihistamines and glucocorticoids. The immediate management of anaphylaxis is not guided by randomised placebo-controlled trials which are unethical due to the potential for rapid progression to fatality arising from delay of treatment. The use of adrenaline (epinephrine) is widespread and recommended in multiple guidelines as first-line therapy based upon results of uncontrolled studies [18]. However, recommendations for use of adjunctive agents such as antihistamines and glucocorticoids are more heterogeneous. The use of H1-antagonists as a first-line agent is not recommended, as they are of slow onset, fail to relieve bronchospasm or gastrointestinal symptoms, and have anticholinergic effects which can induce drowsiness and confuse the clinical picture in a critically ill patient [19]. Similarly, glucocorticoids do not acutely relieve symptoms but prevent prolonged or biphasic symptoms of anaphylaxis [18]. These agents are best used in conjunction with, rather than in place of adrenaline.4. Conclusion
    Anaphylactic reactions can occur to the benzyl benzoate component of depot preparations of testosterone undecanoate. It is potentially unrecognised or can be misdiagnosed as oil embolism and underreported. Testing for reactions to the individual components of ************** agents may prevent inappropriate exclusion of all available preparations of a particular agent if it is the vehicle rather than the active ingredient that is causative. Similarly, it will alert the patient to risk of hypersensitivity to unrelated products which may utilise the same agent. Doctors should remain aware of the potential for serious reactions to testosterone replacement therapies and should consider appropriate further investigation.Conflict of Interests
    There is no conflict of interests that could be perceived as prejudicing the impartiality of the research reported. This research did not receive any specific grant from any funding agency in the public, commercial, or not-for-profit
    sector.
    ____________________________________________

    And last but not least!

    Acute respiratory distress following intravenous injection of an oil-steroid solution


    Abstract
    A case of acute respiratory distress and hypoxemia following accidental intravenous injection of an oil-steroid solution in a body builder is presented. Chest roentography at the time of presentation showed diffuse bilateral opacities, and computed tomography revealed predominantly peripheral ground-glass opacifications. The patient’s symptoms gradually improved over 48 h and imaging of the chest was unremarkable one week later. The pathophysiology, diagnosis and treatment of this rare but potentially life-threatening complication of intravenous oil injection are discussed.
    Keywords: Pulmonary oil embolism, Steroid-oil injection

    Go to:
    CASE PRESENTATION

    A previously healthy 21-year-old man presented to the emergency department with acute onset dyspnea approximately 24 h following self-administered injection of an oil-steroid solution into his right buttock. The patient admitted to a single injection of a mixture of anabolic steroids suspended in oil, including commercially available preparations of testosterone enanthate and boldenone undecylenate. At the time of injection, he aspirated blood before administering the anabolic steroid, then repositioned but did not withdraw the needle. Within 1 min of injection, he developed transient shortness of breath that resolved initially but subsequently recurred and progressed to the point he presented to the emergency department 24 h later.

    Medical history was significant for a previous emergency room assessment for acute respiratory distress, at which time pulmonary embolus was ruled out with a computed tomography (CT)-pulmonary embolism protocol. The patient was a nonsmoker, and denied recreational or intravenous drug use, significant alcohol use or any recent unusual inhalation exposures. He was self-employed as a tattoo and graphic design artist. The patient indicated that he had been sexually active with multiple partners over the previous year and had tested negative for both HIV and hepatitis C virus within the year before presentation.

    The patient was hypoxic at rest, with oxygen saturations of 88% to 92% on peripheral pulse oximetry, and experienced significant desaturation to 82% to 85% with minimal activity. Heart rate, blood pressure and temperature were within normal limits. A physical examination revealed a fit man of average height and weight with a muscular build. The patient’s work of breathing was normal when stationary, but he rapidly became tachypneic on exertion. Lung auscultation revealed decreased breath sounds in the lower lung fields, with coarse crepitations and faint expiratory wheezing bilaterally, as well as a mildly prolonged expiratory phase. The remainder of the physical examination was unremarkable, notably including an absence of petechial rash and a grossly normal neurological examination.
    Complete blood count plus differential, serum electrolytes and coagulation studies were within normal limits. D-dimer was elevated at 1.43 mg/L (upper limit of normal for reference range 0.51 mg/L). An electrocardiogram and urinalysis were unremarkable. Arterial blood drawn in the emergency department for gas analysis on room air demonstrated mild alkalosis (pH 7.45, calculated HCO3 25 mmol/L) and significant hypoxemia (arterial PO2 54 mmHg) with no evidence of hypercapnia (arterial PCO2 36 mmHg).
    A chest x-ray taken at the time of initial assessment showed diffuse bilateral opacities (Figure 1A) and CT-pulmonary embolism of the thorax revealed multifocal regions of ground-glass opacification in a predominantly peripheral distribution throughout the lungs, but no evidence of pulmonary embolus (Figure 1B). The patient was admitted with a working diagnosis of pulmonary oil embolism and started on supplemental oxygen therapy at 2 L/min via nasal cannula.

    DISCUSSION
    The present report is the first to describe a case of pulmonary oil embolism following accidental intravascular injection of an oil-steroid solution. Acute lung injury and respiratory distress following intravascular introduction of oil is uncommon and has only been described in a small number of case reports (1–6). The pathophysiology underlying this phenomenon is postulated to be similar to that observed with the more extensively studied fat embolism syndrome (FES). Although the precise mechanism by which intravascularization of lipid emboli leads to the clinicalfeatures of FES has yet to be completely described, two theories have been proposed to explain the pulmonary dysfunction that occurs.
    The mechanical theory postulates that fat emboli become physiologically lodged in the pulmonary capillaries, resulting in a ventilation-perfusion mismatch. Alternatively, the biochemical theory suggests that hormonal changes induce the systemic release of free fatty acids that are toxic to pneumocytes and the capillary endothelium of the lung, causing interstitial hemorrhage, edema and chemical pneumonitis (7). A symptom-free period precedes the development of clinical features, suggesting that the formation of toxic biochemicals is necessary for the clinical syndrome to develop. The mechanical and biochemical theories are not mutually exclusive and the clinical picture associated with pulmonary oil embolism likely results from several physiological processes.

    FES is characterized by an initial asymptomatic latent period following introduction of lipid emboli into the systemic circulation, with subsequent development of ventilation-perfusion mismatch and toxic insult to pneumocytes and capillary endothelial cells resulting in dyspnea, tachypnea and hypoxia within 12 h to 72h after lipid embolization (7). The clinical presentation of FES is highly variable, ranging from asymptomatic to mild respiratory distress, hypoxia and non-productive cough, to the life-threatening triad of FES consisting of respiratory difficulty, petechial hemorrhages and neurological changes. The classic triad of FES is relatively uncommon, occurring in only 3% to 4% of cases despite the relatively high incidence of fat emboli following long bone fractures (greater than 90%) (8–10). The relatively low incidence of symptomatic events following intravascular introduction of lipid emboli suggests that the majority of cases of lipid embolization are not clinically relevant and go undetected.
    Diagnosis of respiratory distress due to intravascular oil embolization can be challenging given the nonspecific nature of the symptoms and the latent period that often precedes symptom onset. Bronchoalveolar lavage to detect fat droplets in alveolar macrophages has been examined as a means to diagnose pulmonary fat emboli (11); however, the invasive nature of this procedure limits its utility as a diagnostic tool. Furthermore, no uniformly specific diagnostic imaging findings have been described to date. However, several case reports have identified patterns that may be suggestive of pulmonary lipid embolism in the appropriate clinical setting.

    Kiyokawa et al (3) reported finding a combination of interstitial and alveolar patterns in a peripheral-predominant distribution on chest roentography in a case of acute lung injury following intentional injection of vegetable oil. The authors noted, however, that in most cases, chest x-ray findings are normal. Arakawa et al (12) reviewed chest roentograms and CT scans of six patients with pulmonary FES, and found focal areas of consolidation and/or ground-glass opacities with a predominantly upper lobe distribution as well as diffuse ground-glass opacification in the majority of cases. Moreover, Malagari et al (8) described bilateral ground-glass opacities with a predominantly peripheral distribution on high-resolution CT imaging of the thorax in mild pulmonary FES. Although not diagnostic of fat embolism, these imaging patterns – similar to those observed in the present case – may be suggestive in the setting of a compatible history and physical findings. Although specific features on high-resolution CT imaging of the chest were reported in this case series, the diagnostic value of this imaging pattern in the setting of a highly variable clinical picture remains to be determined.

    Treatment options in cases of suspected or confirmed pulmonary oil embolism have been largely limited to supportive care in previous reports of intravenous lipid injection (1–6). Chin et al (13) reported the successful treatment and subsequent resolution of one case of idiopathic lipoid pneumonia with oral prednisolone. However, we were unable to locate any other reports or controlled studies to validate the use of steroids as a therapeutic option in the treatment of pulmonary lipid emboli. Therefore, the best treatment at this time remains early diagnosis and introduction of supportive care measures.


    CONCLUSION

    In contrast to classic cases of FES, which are typically preceded by a symptom-free latent period, the patient described in the present report experienced an acute dyspneic reaction following introduction of oil into the blood stream. Similar reactions preceding the development of overt pulmonary lipiodol embolism have been described within 1 h of transcatheter arterial chemoembolization for hepatocellular carcinoma (14), suggesting that introduction of lipid droplets into the circulation can lead to rapid onset of respiratory distress. The injection of oil-steroid solution was unwitnessed in the present case and it was, therefore, difficult to discern whether the initial shortness of breath was truly respiratory difficulty due to arterial injection of oil or more a subjective experience related to the injection event itself.
    The patient’s condition improved dramatically over the 36 h following initial presentation, and he was subsequently discharged home with a resting oxygen saturation of 93%, with desaturation to 90% on exertion. Chest x-rays at the time of discharge and one week later (Figure 1C) were both unremarkable, with no evidence of the bilateral changes seen on the initial roentograms.

    The present case illustrates the need for timely diagnosis of pulmonary oil embolism and institution of supportive care measures to limit the morbidity and mortality associated with this rare, but potentially life-threatening condition. A high index of suspicion is necessary to make an accurate diagnosis given the variability of clinical presentation and the relative paucity of specific findings on diagnostic imaging and laboratory testing results. However, in the setting of acute respiratory distress and a mechanism of injury suspicious for vascular introduction of lipid emboli, chest roentography and CT can be useful in prompting physicians to consider the possibility of pulmonary oil embolus as a diagnosis.


  15. #15
    Member

    GottaGetGains's Avatar


    Join Date
    Sep 2019
    Posts
    81

    Thanks Thanks Given 
    32
    Thanks Thanks Received 
    21
    Thanked in
    12 Posts
    Rep Points
    4495299

    Wow. I just read every single bit of that. In fact, the article about the 21-year old man was the first thing I read when I googled something along the lines of, ''cough after testosterone injection'' and that scared the shit out of me which prompted me to make this thread to hear the community's thoughts.

    I did not experience an cough or any trouble breathing after the injection, I just happened to develop a cough within a few hours after an into the next day. This is not a dry cough, there if definitely flim/mucous coming up so I may seriously just be getting a cold that ironically decided to onset after the injection. being my first cycle, of course i'm nervous as hell.

    It is comforting to know that the extreme cases are very rare. It seems that most cases it is a quick coughing spell that resides shortly after but will scare the life out of you. I do not aspirate, but this makes me firmly believe I should. Thoughts on this?

    I'm definitely not worried about anaphylaxis, if my body were to have a severe reaction it, I would think, would of happened after the first injection.

Similar Threads

  1. Replies: 17
    Last Post: 01-30-2017, 05:23 PM
  2. Replies: 0
    Last Post: 12-16-2016, 09:32 AM
  3. Question about woman and testosterone injection
    By johnjohn in forum Anabolic Steroids
    Replies: 58
    Last Post: 09-14-2015, 06:08 AM
  4. Had my first post injection coughing fit this morning
    By JMB1911 in forum Anabolic Steroids
    Replies: 12
    Last Post: 02-06-2015, 10:44 AM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •  
Copyright© 2012-2019 Anabolic Steroid Discussion Forums